A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Clinical trial NCT00473889 · TERMINATED

Trial details

NCT number: NCT00473889
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stage IIIB or IV Non-Small Cell Lung Cancer

Start date: 2007-05-01
Primary completion: 2008-12-01
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.